Tacrolimus and pure red-cell aplasia.
Gregoor
Peter Smak
PS
Weimar
Willem
W
D000328:Adult; D016572:Cyclosporine / Q000009:adverse effects / Q000494:pharmacology; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology; D007676:Kidney Failure, Chronic / Q000628:therapy; D016030:Kidney Transplantation / Q000379:methods*; D008180:Lupus Erythematosus, Systemic / Q000628:therapy; D008297:Male; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000494:pharmacology; D012010:Red-Cell Aplasia, Pure / Q000209:etiology*; D016559:Tacrolimus / Q000494:pharmacology*
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D009173:Mycophenolic Acid; D016559:Tacrolimus